OP-8 SECOND LINE THERAPY IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND INADECUATE RESPONSE: ARE WE CHOOSING THE RIGHT TARGET POPULATION FOR CLINICALS TRIALS? Daniela De La Viña; Natalia Sobenko; Eduardo Mullen; Ignacio Lucero; Juan Carlos Bandi; Maria Alejandra Villamil;

P- 63 UTILITY OF TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT IN TREATING COMPLICATIONS OF PORTAL HYPERTENSION: EXPERIENCE IN UNIT OF LIVER TRANSPLANTATION IN URUGUAY Romina Rey; Martin Elizondo; Juan Carlos Bandi; Marcelo Vicente Valverde; Solange Gerona;

O-32 FULMINANT AUTOIMMUNE HEPATITIS: CLINICAL PRESENTATION, OUTCOME AND PROGNOSTIC FACTORS. Alejandra Villamil; Marlene Padilla; Eduardo Mullen; Juan Carlos Bandi; Gabriel Carballo; Natalia Sobenko; Sebastian Marciano;